Quarterly Call Option Transactions in Corvus Pharmaceuticals, Inc. (CRVS)
This table provides information about the institutional ownership of Corvus Pharmaceuticals, Inc. (CRVS) during . The information is specifically focused on institutions that hold call options of Corvus Pharmaceuticals, Inc..
Calls Purchased
Calls Sold
Quarter | Buy | Sell | Net Activity | |||||
---|---|---|---|---|---|---|---|---|
New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
Q3 2021 | 470,700 | 501,320 | 972,020 | — | 972,020 | |||
Q4 2021 | 11,500 | 0 | 11,500 | 414,200 | 94,900 | 509,100 | -497,600 | |
Q1 2022 | 0 | 13,700 | 13,700 | 55,700 | 22,700 | 78,400 | -64,700 | |
Q2 2022 | — | 14,400 | 13,900 | 28,300 | -28,300 | |||
Q3 2022 | — | 13,100 | 0 | 13,100 | -13,100 | |||
Q4 2022 | — | 1,200 | 0 | 1,200 | -1,200 | |||
Q1 2023 | 0 | 12,500 | 12,500 | — | 12,500 | |||
Q2 2023 | 6,900 | 39,400 | 46,300 | — | 46,300 | |||
Q3 2023 | 0 | 16,800 | 16,800 | 8,100 | 0 | 8,100 | 8,700 | |
Q4 2023 | — | 26,600 | 0 | 26,600 | -26,600 | |||
Q1 2024 | 8,400 | 0 | 8,400 | — | 8,400 | |||
Q2 2024 | — | 7,000 | 0 | 7,000 | -7,000 | |||
Q3 2024 | 73,600 | 962,400 | 1,036,000 | — | 1,036,000 |